Ana Belo

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.

Articles by Ana Belo

News

Potential Gene Therapy for Dystrophic EB, KB103, Named an Orphan Drug by FDA

A potential gene therapy for dystrophic epidermolysis bullosa (DEB), KB103 by Krystal Biotech, has been designed an Orphan…

News

BERG Receives Partners in Progress Award for Efforts in Treating Epidermolysis Bullosa

The biopharmaceutical company BERG was honored with a Partners in Progress Award from the Dystrophic Epidermolysis…

Subscribe to our newsletter

Get regular updates to your inbox.